For the March #ColorectalCancerAwareness month Clinical Trial Conversations blog, Maia Walker, Lead Curator of the Fight Colorectal Cancer Trial Finder and I discuss colorectal cancer clinical trials for Minimal Residual Disease. I cover COBRA, CIRCULATE-US and ACT-3 which are trials for early-stage CRC. Maia talks about vaccine and adoptive cell therapies for those who are MRD positive including the AMPLIFY-201, CLAUDE and two other trials.
Here’s the link on the FightCRC website:
Clinical Trials for Early-Stage Colorectal Cancer or Minimal Residual Disease